Detalhe da pesquisa
1.
Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis.
Liver Int
; 43(12): 2611-2614, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916574
2.
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction. / Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica.
Gastroenterol Hepatol
; 46(2): 150-162, 2023 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36257502
3.
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.
J Viral Hepat
; 29(3): 227-230, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806812
4.
Cost-effectiveness analysis of an active search to retrieve HCV patients lost to follow-up (RELINK-C strategy) and the impact of COVID-19.
J Viral Hepat
; 29(7): 579-583, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35555847
5.
Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain.
Rev Esp Enferm Dig
; 109(12): 809-817, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29152988
6.
Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain. / Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España.
Gastroenterol Hepatol
; 40(7): 433-446, 2017.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-28645446
7.
Impact of the COVID-19 pandemic on HCV elimination in Spain.
J Hepatol
; 74(5): 1246-1248, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358780
8.
[Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis]. / Análisis coste-efectividad de sofosbuvir, interferón pegilado y ribavirina en pacientes con hepatitis crónica por virus C: tratamiento precoz en fases iniciales de fibrosis vs. tratamiento tardío en fases avanzadas.
Gastroenterol Hepatol
; 39(7): 449-57, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-27084669
9.
Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities.
Adicciones
; 27(3): 179-89, 2015 Sep 15.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-26437312
10.
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.
JHEP Rep
; 6(1): 100932, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38074506
11.
Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions.
Enferm Infecc Microbiol Clin (Engl Ed)
; 41(10): 589-595, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710166
12.
Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain.
PLoS One
; 17(12): e0278544, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454996
13.
Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C.
PLoS One
; 16(12): e0260608, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928962
14.
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study).
Orphanet J Rare Dis
; 16(1): 186, 2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902672
15.
The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy. / La simplificación del proceso de diagnóstico de la hepatitis C crónica es una estrategia coste-efectiva.
Enferm Infecc Microbiol Clin (Engl Ed)
; 37(10): 634-641, 2019 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-30982677
16.
Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
PLoS One
; 13(11): e0208036, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485377